Mission Wealth Management LP Has $261,000 Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Mission Wealth Management LP trimmed its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 16.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 7,258 shares of the pharmacy operator’s stock after selling 1,400 shares during the period. Mission Wealth Management LP’s holdings in Walgreens Boots Alliance were worth $261,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of WBA. NN Investment Partners Holdings N.V. increased its holdings in shares of Walgreens Boots Alliance by 24.1% in the second quarter. NN Investment Partners Holdings N.V. now owns 143,769 shares of the pharmacy operator’s stock valued at $6,095,000 after purchasing an additional 27,922 shares during the last quarter. Citizens Financial Group Inc RI increased its holdings in shares of Walgreens Boots Alliance by 42.7% in the second quarter. Citizens Financial Group Inc RI now owns 3,226 shares of the pharmacy operator’s stock valued at $137,000 after purchasing an additional 966 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 1.4% in the second quarter. Principal Financial Group Inc. now owns 1,159,751 shares of the pharmacy operator’s stock valued at $49,162,000 after purchasing an additional 15,732 shares during the last quarter. FDx Advisors Inc. increased its holdings in shares of Walgreens Boots Alliance by 44.7% in the first quarter. FDx Advisors Inc. now owns 15,959 shares of the pharmacy operator’s stock valued at $730,000 after purchasing an additional 4,928 shares during the last quarter. Finally, Trust Co. of Toledo NA OH increased its holdings in shares of Walgreens Boots Alliance by 5.0% in the third quarter. Trust Co. of Toledo NA OH now owns 6,198 shares of the pharmacy operator’s stock valued at $223,000 after purchasing an additional 295 shares during the last quarter. Institutional investors and hedge funds own 55.96% of the company’s stock.

Several equities analysts recently commented on the stock. Royal Bank of Canada decreased their price target on shares of Walgreens Boots Alliance from $45.00 to $38.00 and set a “sector perform” rating on the stock in a research note on Wednesday, September 2nd. Barclays decreased their price target on shares of Walgreens Boots Alliance from $45.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Thursday, October 8th. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “strong sell” rating and set a $42.00 price target on the stock. in a research note on Friday, July 17th. SunTrust Banks decreased their price target on shares of Walgreens Boots Alliance from $42.00 to $40.00 and set a “hold” rating on the stock in a research note on Friday, July 10th. Finally, Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $45.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 3rd. Five equities research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. The company has an average rating of “Hold” and an average target price of $43.19.

WBA stock opened at $37.41 on Friday. The stock has a market capitalization of $32.42 billion, a P/E ratio of 45.62, a price-to-earnings-growth ratio of 1.35 and a beta of 0.43. The company has a current ratio of 0.69, a quick ratio of 0.33 and a debt-to-equity ratio of 0.57. Walgreens Boots Alliance Inc has a 12 month low of $33.88 and a 12 month high of $64.50. The firm has a 50-day moving average price of $36.42 and a 200-day moving average price of $40.52.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, October 15th. The pharmacy operator reported $1.02 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.06. The firm had revenue of $34.75 billion during the quarter, compared to analysts’ expectations of $34.36 billion. Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. The business’s revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.43 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance Inc will post 4.68 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: NASDAQ

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.